Collection of Real-life Measurement Data for TENA SmartCare Change Indicator in Subjects With Urinary Incontinence
Launched by ESSITY HYGIENE AND HEALTH AB · Aug 26, 2019
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
The purpose of this exploratory clinical investigation is to evaluate safety and to collect real-life measurement data using the TENA SmartCare Change Indicator. The collected data will be used to assess the device related algorithms. These algorithms have been established and verified in a laboratory environment. However, due to possible differences in parameters, real-life measurement data are to be collected to aid in further product development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The subject is willing and able to provide informed consent and to participate in the clinical investigation.
- • 2. The subject is ≥18 years of age.
- • 3. The subject is diagnosed with urinary incontinence.
- • 4. The subject is being cared for at Tre Stiftelser.
- Exclusion Criteria:
- • 1. The subject has ≥ 4 fecal "incidences" per week.
- • 2. The subject has severe absorbent product related skin problems, as judged by the investigator.
- • 3. The subject is hyper sensitive related to allergic reaction to any of the included materials, as judged by the investigator.
- • 4. The subject has ≥ 2 intermittent urinary catheters per day.
- • 5. The subject has a pacemaker or an implantable cardioverter-defibrillator.
- • 6. The subject removes the incontinence product.
- • 7. The subject demonstrates responsive behavior towards sensors.
- • 8. The subject has any other condition that may make participation in the clinical investigation inappropriate, as judged by investigator.
- • 9. The subject is not cared for at Tre Stiftelser.
- • 10. The subject is pregnant or lactating.
About Essity Hygiene And Health Ab
Essity Hygiene and Health AB is a global leader in health and hygiene products, dedicated to improving the well-being of individuals and communities through innovative solutions. With a strong focus on sustainability and research-driven development, Essity offers a comprehensive portfolio of products in areas such as personal care, consumer tissue, and professional hygiene. The company is committed to advancing healthcare practices through clinical trials that enhance product efficacy and safety, ultimately aiming to meet the evolving needs of consumers and healthcare professionals worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Patients applied
Trial Officials
Ulla Molander, MD, PhD
Principal Investigator
Avd. för Invärtes medicin och klinisk nutrition, Högsbo sjukhus, Göteborg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials